A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer.

MLA

Murphy, Claire, et al. “A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer.” The Prostate, vol. 76, no. 14, Oct. 2016, pp. 1285–92. EBSCOhost, https://doi.org/10.1002/pros.23215.

APA

Murphy, C., True, L., Vakar-Lopez, F., Xia, J., Gulati, R., Montgomery, B., & Tretiakova, M. (2016). A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer. The Prostate, 76(14), 1285–1292. https://doi.org/10.1002/pros.23215

Chicago

Murphy, Claire, Lawrence True, Funda Vakar-Lopez, Jing Xia, Roman Gulati, Bruce Montgomery, and Maria Tretiakova. 2016. “A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer.” The Prostate 76 (14): 1285–92. doi:10.1002/pros.23215.